Background and aims Adolescents with conduct and substance use problems are at increased risk for premature
INTRODUCTION
Adolescence and early adulthood are periods of elevated risk for unnatural death; homicide, suicide and unintentional injury accounted for 71% of the 936 000 deaths of young people in the United States (aged 15-29 years) between 1999 and 2016 [1] . However, the risk of early death is not distributed evenly. American youth who engage in risk behaviors, such as substance abuse and criminal activities, are two to nine times more likely to die prematurely than their general population counterparts [2] [3] [4] [5] , and their deaths are disproportionately caused by homicide, legal intervention and motor vehicle accidents [2] [3] [4] [5] [6] [7] [8] [9] [10] . Youth with conduct-or substance-related problems (referred to hereafter as adolescents with externalizing problems) can often be identified through involvement in juvenile correction systems and/or placement in treatment programs; therefore, they comprise a prime target for intervention and prevention efforts. Nevertheless, our current understanding of the independent contributions of potentially modifiable risk factors for mortality hazard-information crucial to the success of such efforts-is incomplete.
Previous research has identified numerous demographic variables and individual differences that predict premature mortality among adolescents and young adults with externalizing problems, including male sex [3, 4, 7, 11] , minority ethnic status (i.e. Black/African American or Latino) [2] [3] [4] 7, 9, 11] , substance abuse [2, 3, 5, 6, [11] [12] [13] and previous criminal history [2, 7, 9] . These findings mirror studies of mortality in previously incarcerated individuals [14] [15] [16] [17] [18] [19] [20] . However, with few exceptions [6, 11] , recent studies have compared the mortality risk for youth with externalizing problems to those from retrospectively obtained population-level data rather than prospectively ascertained comparison cohorts [2] [3] [4] 7, 12, [21] [22] [23] [24] . Additionally, no prior study has analyzed the independent contributions of conduct disorder (CD) and substance use disorders (SUD) among legally ascertained youth to determine hazard of premature death despite evidence of substantial psychiatric morbidity in delinquent youth populations [25] and elevated mortality risk in clinically ascertained youth [5, 11] . Further, although both genetic and environmental familial factors contribute to conduct problems and substance abuse [26] [27] [28] , no study has examined whether these identified risk factors for premature death account for independent or redundant variance beyond that explained by demographics, or whether familial effects remain salient after accounting for individual differences. In particular, it remains unclear whether severity of substance abuse increases mortality hazard after accounting for CD, a point of clinical relevance given that several researchers have suggested that further dissemination and implementation of SUD treatments will reduce mortality in youth with externalizing problems [5, 13] . Finally, it is unknown whether risk for premature death is heightened among siblings of adolescents with externalizing problems, and whether any differences between clinically ascertained youth and their siblings are evident after accounting for individual differences in CD and SUD severity.
In light of these current limitations, the present study sought to examine the independent mortality hazard conferred by previously identified risk factors. We addressed the following aims in a multi-site, longitudinal, prospective cohort study of youth ascertained for CD and SUD (clinical probands), their siblings and matched community controls: 1 Comparison of mortality risk and cause of death between clinical probands, their siblings and controls. We hypothesized that mortality risk will be highest in the clinical probands and that shared familial factors will place their siblings at elevated risk with respect to controls (although not at the level of the clinical probands). Additionally, we expected that CD-and SUD-related causes of death (e.g. homicide, legal intervention and overdose) would account for group differences. 2 Examination of the independent and simultaneous risk for premature death conferred by CD and SUD severity, beyond demographic variables and controlling for within-family dependence, among youth with externalizing problems and community controls. We hypothesized that individual differences in CD and SUD severity would explain unique variation in mortality risk beyond that due to clinical/control status and demographic factors.
METHODS

Participants
This prospective cohort study examined a sample of youth ascertained for CD and SUD [total 3766 (1168 female); clinical probands; n = 1463 (254 female)], their siblings [n = 1399 (651 female)], community controls matched to clinical proband demographics by age and sex [n = 401 (35 female)] and their siblings [n = 503 (228 female)]; distinguishing between matched controls and their siblings failed to impact any of our results substantially, so we collapsed these individuals into a single designation of controls for clarity (results presented in Supporting information, Table S1 illustrate that this choice did not affect primary conclusions) participating in a study of familial transmission and genetic linkage of SUD and CD between 1993 and 2016 (Genetics of Antisocial Drug Dependence Study) [29] [30] [31] [32] . Clinical probands were recruited from individuals currently involved in or referred to residential and outpatient treatment facilities for substance abuse and delinquency in the Denver, Colorado area (n = 941) from adjudicated adolescents involved in the Colorado juvenile correctional system (n = 288) and from two schools for troubled youth in the San Diego, California area (n = 234). Within the Denver residential and out-patient treatment site, three separate rounds of ascertainment occurred following original funding and funding renewals; we treat these as separate sites in our analyses. Within the San Diego site, participants' schools were not recorded, preventing modeling efforts to account for additional dependence due to nesting of observations within institutions, although analyses excluding the San Diego site were consistent with primary results (Supporting information, Table  S2 ). To be admitted to the study, clinical probands had to be judged by staff as not currently psychotic, severely developmentally delayed, suicidal or homicidal and to have no physical illness or current intoxication which would prevent participation in treatment or evaluation.
Research staff contacted those who met eligibility requirements for the study and invited them to participate. Written consent from a parent or guardian and assent from the patient were obtained for all subjects after complete description of the study. Subjects were paid between $20 and $100 for participation, with payment increasing over time. The respective institutional review boards approved all procedures. The mortality data-collection period lasted through the end of 2016, with an average age at assessment of 16.79 years [standard deviation (SD) = 2.75] and an average age at study conclusion or death of 32.69 years (SD = 5.04). Additional demographic information is presented in Table 1 .
Measures
Demographic measures
Information regarding age, sex, race, and ethnicity was collected by self-report at enrollment.
Substance abuse/dependence
Substance use was assessed via the Composite International Diagnostic Interview-Substance Abuse Module (CIDI-SAM) [33] . The CIDI-SAM provided diagnostic data regarding the life-time occurrence of four abuse symptoms and seven dependence symptoms on 10 different drug classes [tobacco, alcohol, cannabis, cocaine, amphetamines, sedatives, opiates, phencyclidine (PCP), hallucinogens and inhalants], according to DSM-IV criteria [34, 35] . The number of substances used on at least five separate occasions and the abuse/dependence symptom count per such substance were obtained. From this, we obtained a substance abuse/dependence vulnerability (SADV) index by calculating participants' average number of abuse/dependence symptoms per substance, an approach that has been shown to maximize trait heritability [32] . The decision to use SADV was made a priori. Relevant results were tested for sensitivity to this approach by repeating analyses with multiple alternative variables: the total number of abuse/dependence symptoms across substances, the maximum number of abuse/dependence symptoms for a given substance among substances and substance-dependence diagnosis (e.g. see Supporting information, Table S3 for model based on dependence diagnosis); these substitutions did not influence our results and we present analyses that used SADV.
Conduct disorder
Life-time CD symptom count was assessed using the Diagnostic Interview Schedule for Children (DISC) according to DSM-III-R or DSM-IV criteria depending on the time of study enrollment [36, 37] . Participants were asked to answer questions about individual CD symptoms. The DSM-III-R criteria included 13 symptoms of CD, and the DSM-IV included two additional symptoms. Earlier samples using the DSM-III-R criteria (n = 916) were scored using the DSM-IV criteria for compatibility with newer samples (with the earlier 916 participants missing scores for two items). Among clinical probands who were assessed for all DSM-IV criteria, DSM-III-R-and DSM-IV-derived symptom counts were correlated strongly (r = 0.98, P < 0.001). We present only results based on DSM-IV criteria. 
Mortality
Mortality and cause of death data were obtained through a search of the National Death Index for all participants from the year of study enrollment to the end of 2016 (released October 2017) [38] for determination of mortality status, as suggested by the National Center for Health Statistics [38] . International Classification of Disease 10 (ICD-10) classifications were hand-coded as falling into eight non-mutually exclusive categories: (nontraffic) physical accidents, medical conditions, traffic accidents, assault, suicide, substance-related incidents, legal intervention-related incidents and firearm-related incidents [39] . For example, death due to 'intentional self-harm by handgun discharge' was coded as both suicide-and firearm-related. Specific coding used was verified by a licensed physician and patterns of overlap are presented in Supporting information, Fig. S1 .
Analyses
Primary analyses were conducted using the coxme package [40] in the R computing environment [41] . Frailty models (also known as Cox proportional hazards models with Gaussian random effects) were used to examine the association between mortality hazard and predictor variables and covariates while controlling for dependence between siblings via a random intercept (frailty) term among both clinical and control subjects. First, univariate frailty models were employed (Table 2) to examine the contributions of sex, sample, ethnicity, clinical/control designation, proband/sibling designation, substance/abuse dependence vulnerability and CD symptom count to hazard of mortality. Next, multivariate frailty models (Table 3) were used to examine evidence of independent contributions of these predictors. In all models, site was included via the fixed effects of a set of orthogonal contrast codes (see Table 2 for further details). To elucidate patterns of redundancy among predictors, further analyses were conducted with several informative subsets of predictors (Supporting information, Table S5 ). Proportional hazards assumptions were validated using the survival package [43] . Listwise deletion was employed in primary analyses (202 participants were missing measures of SADV or CD symptoms), but possible consequences of non-random missing data were examined in supplementary sensitivity analyses (Supporting information, Table S4 ). For all models, an alpha-level of 0.05 was used to determine significance.
RESULTS
Cause of death
Substance-related deaths comprised the plurality of observed deaths overall and throughout male and female participants, accounting for 20 of 62 deaths among clinical probands (32%), seven of 34 deaths among their siblings (21%) and one of eight deaths among controls (13%; Table 4 ). Traffic accidents were the second most prominent cause, accounting for 12 deaths among clinical probands (19%), seven among their siblings (21%) and one among controls (13%). Violent deaths (related to suicide, assault or legal intervention) together accounted for 26 deaths among clinical probands (42%), 10 among their siblings (31%) and two among controls (26%). Note that percentages for controls are poor estimates, as mortality was relatively uncommon. Additionally, three deaths classified as suicides were also classified as substancerelated, as overdose was the mechanism of suicide (see Supporting information, Fig. S1 for patterns of overlap between causes). Probands recruited from residential and outpatient treatment facilities for substance abuse and delinquency in the Denver, Colorado area were ascertained in the context of three separate waves of funding, each of which was treated as a separate site in case of cohort-specific differences, resulting in five total sites and four orthogonal contrasts. b Group variables were estimated using orthogonal codes together in a single analysis of deviance (χ 2 (2) = 39.53, P < 0.001). We present four contrasts of interest above, although only two contrasts are identifiable in the context of a single model. c Slopes are unstandardized and are to be interpreted relative to unit increases in average abuse/dependence symptoms per substance and in total symptom counts for substance abuse/dependence vulnerability and conduct disorder symptoms, respectively. HR = hazard ratio; CI = confidence interval; SE = standard error.
Univariate frailty models
After accounting for lack of independence due to family, all predictors other than site (χ 2 (4) = 0.47, P = 0.976) and ethnicity (χ 2 (3) = 3.59, P = 0.309) evidenced contributions to hazard of mortality (Table 2) . Males had 2.81 times the expected hazard as females (Z = 3.56, P < 0.001) and clinical probands had 1.95 times the expected hazard as their siblings (Z = 3.07, P = 0.002) who, in turn, had 3.58 times the expected hazard, as did controls (Z = 3.27, P = 0.001). Single average symptom per substance in SADVand single symptom increases in CD were associated, respectively, with 1.16-and 1.18-fold increases in expected hazard (Z = 3.92, P < 0.001; Z = 5.68, P < 0.001).
Multivariate frailty models
Not all predictors evidenced independent contributions to hazard in models with greater saturation (Supporting information, Table S5 ). Specifically, independent contributions of SADV were not evident in any models including group or CD symptoms simultaneously (min. P = 0.190). The fully saturated model (Table 3) provided evidence for independent contributions of sex [hazard ratio (HR) = 2.09, Z = 2.29, P = 0.020], clinical/control contrast (HR = 4.20, Z = 3.32, P = 0.001) and CD symptoms (HR = 1.09, Z = 2.20, P = 0.028), but not for SADV (HR = 0.98, Z = À0.30, P = 0.770) or for clinical proband/sibling contrast (HR = 1.14, Z = 0.47, P = 0.640). However, siblings of clinical probands continued to evidence greater adjusted hazards than controls (HR = 3.58, Z = 3.21, P = 0.001). Using total number of abuse/dependence symptoms or maximal number of abuse/dependence symptoms for any given substance not change this pattern of results (max. P = 0.037 for terms associated CD symptom count, min. P = 0.54 for terms associated with alternative substance abuse variables). Effects of site or ethnicity were not evident in any of the models (Table 2 , Supporting information, Table S5 ). Additionally, we conducted a series of sensitivity analyses examining possible consequences of multiple schemes of non-random missingness of baseline predictors. Our results suggested that such artifacts were unlikely to have driven our primary conclusions (Supporting information, Table S4 , Fig. S2 ).
As we found little evidence for an independent contribution of SADV after accounting CD symptoms and additional covariates, we re-estimated the full multivariate frailty model twice, once substituting binary diagnoses of substance dependence and CD for SADVand CD symptoms, respectively (Supporting information, Table S3 ), and again including a SADV × CD symptoms product term in addition to their simple effects (Supporting information, Table S6 ). Results derived from the diagnosis-based model were directionally consistent with those of the primary frailty model, but with greater uncertainty regarding slope estimates. Specifically, CD diagnosis was no longer significant (HR = 1.43, Z = 1.29, P = 0.200), due presumably to the reduction in power associated with dichotomizing continuous predictors and greater collinearity with the clinical versus control contrast (Supporting information, Table S3 ). There was no strong evidence of an interaction between SADV and CD symptoms (HR = 1.01, Z = 0.49, P = 0.330) and simple effects were directionally consistent with the primary model excluding the interaction term (Fig. 1, Supporting information, Table S6 ).
DISCUSSION
The present prospective, multi-site study examined demographic and psychiatric predictors of early mortality in a sample of youth ascertained for CD and SUD, their siblings and community controls. This study is the first, to our knowledge, to distinguish between the relative risk for premature death conferred by individual differences versus Fully saturated frailty model estimating the simultaneous independent contributions of the predictors to mortality hazard on the multiplicative scale while accounting for dependence due to family. Generalized variance inflation factor (GVIF
) is a linear indicator of multicollinearity of predictors; greater values indicate greater collinearity with other predictors [42] . a Probands recruited from residential and out-patient treatment facilities for substance abuse and delinquency in the Denver, Colorado area were ascertained in the context of three separate funding efforts, each of which was treated as a separate site in case of cohort-specific differences. Slopes are unstandardized and are to be interpreted relative to unit increases in average abuse/dependence symptoms per substance and in total symptom counts for substance abuse/dependence vulnerability and conduct disorder symptoms, respectively. HR = hazard ratio; CI = confidence interval; SE = standard error.
familial factors and to examine the independent risk conferred by SADV after accounting for CD symptoms, demographic factors and dependence due to family. In line with hypotheses, clinical probands evidenced significantly higher mortality hazard than their siblings who, in turn, evidenced greater hazard than controls. Substance-related and violent causes accounted for the majority of deaths among clinical probands and their siblings, with the substance-related causes accounting for 32% of deaths among clinical probands (Table 4) . Results from univariate models confirmed previous findings that male sex [3, 4, 7, 11] , conduct problems [2, 7, 9] and SAD [2] [3] [4] [5] [6] [7] [11] [12] [13] are each associated with increased mortality risk ( Table 2) .
Contrary to expectation, multivariate model results suggested that the risk conferred by individual differences in SADV was largely redundant with that due to CD (Table 3 , Supporting information, Table S5 ). That is, there was no discernible independent effect of SADV in any models accounting for CD symptoms or clinical ascertainment status, although the latter accounted for independent variance regardless of which covariates were presented in the model. However, consistent with previous findings [3, 5, 13, 19, 44, 45] , substance-related causes comprised the largest proportion of observed deaths and occurred disproportionately among clinical probands and their siblings vis-á-vis controls. In light of these findings, we echo previous researchers' recommendations [5, 13, 16] , that intervention and prevention efforts include SUD treatment within constellation treatment foci including additional psychiatric resources and social services.
Further complicating this discussion, the determination of cause of death as substance-related versus suicide is often ambiguous with respect to available evidence, and misclassification errors are ubiquitous [46] [47] [48] . Some researchers have suggested that substance-related suicides are particularly likely to be classified erroneously as accidental or undetermined [47, 48] . The degree to which deaths classified as physical or traffic accidents might have indirect consequences of substance use is unknown. Additional limitations to the present study include the lack of a comprehensive measure of socio-economic status (SES), inadequate measures of race/ethnicity among multi-ethnic individuals (Table 1 ) and potential regional specificity to site locations (urban Colorado and southern California), although the first was mitigated partially by the inclusion of familial random intercepts and there was no evidence of site differences among our samples. Furthermore, the contrasts between clinical probands and their siblings may have reflected ascertainment procedures rather than individual differences. That is, it is possible that the older or younger siblings of probands might themselves have been ascertained as probands had ascertainment occurred at a different date. Additionally, as the present Observed cause-of-death information as reported by the National Death Index split by group and by sex. Causes were established by categorizing International Disease Classification 10 codes and were verified by a licensed physician. Not all categories were mutually exclusive; for example, death due to 'intentional self-harm by handgun discharge' was coded as both suicide-and firearm-related. Patterns of overlap are presented in Supporting information, Fig. S1 . study focused upon individuals ascertained specifically for severe externalizing behaviors, their siblings and community controls, the extent to which our results might generalize to individuals with moderate externalizing problems is unclear. That is, our results concerning the independent risk attributable to substance versus conduct problems might not generalize to youth with subclinical externalizing problems or who avoid legal or clinical attention. Further, our results do not reflect the diagnostic criteria currently employed in the DSM-5, although we are skeptical that employing DSM-V criteria would have altered our results dramatically; symptoms for CD remained unchanged and substance abuse/dependence symptoms saw only the replacement of the legal troubles criterion with a craving criterion [49, 50] . The utility of the callous-unemotional traits CD subtype specifier in predicting premature mortality remains unknown. Lastly, the National Death Index search probably failed to identify some deceased participants; a family member reported the death of one participant that our search did not identify as deceased. In the present study, the full name and date of birth were available for all participants, and social security numbers were available for a subset of participants. Previous research suggests that the sensitivity and specificity of NDI searches are greater than 90% even for those missing social security numbers [51] . However, whether these estimates generalize to samples with relatively high incidences of unnatural death early in life is unknown.
The degree to which forensic artifacts surrounding cause-of-death classification account for the incidence of substance-related deaths among clinically and legally ascertained youth comprises a prime target for future research efforts. Additionally, future work should examine the independent contributions of SUD and CD to premature mortality in the context of thorough measures of SES. Finally, we wish to caution that although it remains unclear which domains comprise the most pressing target for intervention and prevention efforts (e.g. targeting SUD versus general psychiatric care), it is clear that youth identified with conduct problems are at extreme risk for premature mortality and in critical need of greater resources.
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